Back to results
US 2020/0368318 A1Published application
Compositions and methods for treatment during non-acute periods following cns neurological injury
AssigneeAcorda Therapeutics, Inc.
InventorsAnthony Caggiano, Jennifer Iaci
Life of this patent
Estimating the term…
Abstract
This invention relates to treatment of neuroinjury in a post-acute window or in a chronic period following neuroinjury.
Claims15
A method for administering a polypeptide comprising an epidermal growth factor-like (EGF-like) domain to a mammal, said method comprising:
- administering a polypeptide comprising an epidermal growth factor-like (EGF-like) domain following neuroinjury in said mammal;
- and, initiating the administering at least two days after the neuroinjury.
A method for administering a polypeptide comprising an epidermal growth factor-like (EGF-like) domain to a mammal, said method comprising:
- administering a polypeptide comprising an epidermal growth factor-like (EGF-like) domain following neuroinjury in said mammal;
- initiating the administering at within six hours after the neuroinjury;
- and,
- continuing the administering step into a time period more than six hours post injury.
1 more element
A method for administering a polypeptide comprising an epidermal growth factor-like (EGF-like) domain following an ischemic central nervous system neuroinjury in a mammal, said method comprising:
- administering the peptide following neuroinjury in said mammal;
- and,
- initiating the administering after the mammal has achieved a complete post-injury ischemic lesion cell death volume.
Dependencies are inferred from the claim text.